Finding the Hidden Costs in Pharmacy Benefits:

Insights from Matt Collier

Kelly Bowman sits down with Matt Collier of IMA Financial Group to explore why pharmacy benefits have become one of the fastest-growing and most complex areas of healthcare spend. Matt explains why many employers lack visibility into their PBM contracts, how spreadsheet comparisons can miss important contract details, and why words, exclusions, rebate structures, audit rights, and pricing guarantees all matter.

They discuss IMA Pharmacy Consulting, the importance of transparency and accountability, the role of regulation, and why employers should begin evaluating their pharmacy strategy now instead of waiting for new rules to take effect. Matt also breaks down specialty drug costs, GLP-1 coverage considerations, biosimilars, prior authorization, step therapy, IMARx, and the difference between a lowest net cost strategy and a rebate- driven approach. Whether you are reviewing your PBM contract, preparing for an RFP, or simply trying to understand where pharmacy spend is going, this episode offers a practical roadmap for taking a more proactive approach.

Listen to this episode below.